Medicover sells India hospitals unit to KKR for €1.2 billion

Medicover agreed to sell its India hospital business to KKR for €1.2 billion, a deal that puts one of India’s private hospital networks under the control of a global buyout firm. The transaction lands in a market where private capital has been chasing beds, diagnostics and operating scale as demand for care keeps rising.

Medicover said it expects to receive about €740 million, or roughly $855 million, because it owns about 66% of Medicover Hospitals India; minority shareholders hold the rest. Medicover Hospitals India was established in 2017 and now operates 24 hospitals with about 4,800 beds across South and West India. The sale is expected to close in the fourth quarter of 2026, subject to customary closing conditions and regulatory approvals.

Interest in the asset had already been building. On June 18, KKR was eyeing at least a $1 billion stake in Medicover’s India hospital arm, a sign that the business had attracted serious attention before terms were finalized. The scale of the purchase fits a broader pattern in healthcare, where private equity firms have increasingly treated hospitals, diagnostics and other infrastructure as durable assets because demand tends to rise over time even when the wider economy slows.

India is particularly compelling for that kind of capital. Urbanization, a growing middle class, medical tourism and a greater willingness to pay for private care are all supporting expansion, while the country still needs more high-quality hospital capacity. That scarcity matters because hospitals are expensive to run, with constant spending on equipment, staff and facilities, and larger networks can often improve margins by negotiating better terms with suppliers and payers.

Medicover said the divestment will let it focus on Europe and accelerate strategy execution there, rather than continue pouring capital into a capital-intensive hospital network in India. For KKR, the purchase is a classic buyout play in an essential service. The question now is whether the new owner uses that scale to add capacity and improve utilization, or whether consolidation leads to higher pricing power and tighter control over how patients access care.